Filing metadata

Accession number
0001140361-21-005267
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Feb 17, 2021
Reporting period
Feb 17, 2021
Description
Insider transaction

Explore SEC Filings Hub